Other MH Policy · clinical_education

Federal: Other MH Policy

Official titleWhy Menopause Matters in Substance Use Disorder Prevention, Treatment, and Recovery

Federal · Relevance score 28 of 100 (tangential). low impact.

Informational only

This summary is informational and is not legal advice. Read the source text before acting on it.

The itemStructured facts, then the operational reading.

What this policy change does.

Jurisdiction
Federal
Published
May 14, 2026
Impact score
28 of 100, from analysis of the full text: tangential
Primary source
SAMHSA

Impact on your practice

This is educational content for practitioners and the public about a specific clinical population. While useful for therapists treating women in midlife, it does not change policy, reimbursement, or practice requirements.

Key facts

  • SAMHSA educational content on menopause and substance use disorder links
  • Addresses hormonal changes affecting mood, sleep, cognition, stress response
  • Focuses on prevention, treatment, and recovery messaging
  • Targeted to women in midlife transitioning through menopause
The readingGenerated from the full source text, and labelled as analysis rather than fact.

What it would mean for a practice.

This SAMHSA guidance does not create new reimbursement requirements, prior authorization rules, or mandatory documentation standards for your practice. However, it signals a federal clinical priority that may influence insurance coverage decisions, grant funding, and continuing education expectations over the next 2-3 years. If you treat women aged 40-65 with substance use disorders or dual diagnoses (depression, anxiety, insomnia), you should expect increasing referrals with menopause-related presentations and growing pressure from payers to screen for menopause symptoms as part of SUD assessment. Your revenue is not directly affected, but your clinical assessment protocols should evolve: add menopause screening questions to your intake forms for midlife women, particularly around sleep disruption, mood cycling, and substance use patterns. If you're a prescriber (psychiatric NP, psychologist with prescriptive authority in your state), understand that women may self-medicate menopausal symptoms with alcohol or cannabis—this changes your medication management strategy. Group practices and agencies should anticipate that payers may eventually require menopause-informed screening language in your SUD protocols; documentation that you addressed menopause symptoms in your treatment planning could become a compliance expectation within 12-18 months, especially for Medicaid providers treating this population.

Background

Menopause has historically been absent from substance use disorder prevention and treatment frameworks, despite growing evidence that hormonal transition increases relapse risk and complicates recovery. The federal government is now acknowledging this gap. SAMHSA's first-ever menopause symposium (May 2026) represents an institutional shift toward recognizing midlife women as a distinct clinical population within SUD treatment—similar to how pregnant women or adolescents are now routinely integrated into protocol development. This matters now because baby boomers are aging into menopause, and cannabis legalization has expanded substance options available to women seeking symptom relief. Payers, state Medicaid programs, and accrediting bodies are increasingly following federal clinical guidance; when SAMHSA identifies a clinical priority, it typically cascades into state regulations, managed care contracts, and licensing board expectations within 18-36 months.

What you should do

  • Update your substance use disorder intake and assessment tools to include explicit screening questions about menopause stage (perimenopause vs. postmenopause), sleep disruption, mood changes during cycle, and use of alcohol or cannabis specifically for symptom management. Document these findings in every midlife female SUD patient chart.
  • Review your current treatment protocols and care plans for women aged 40-65. If you don't currently address menopause symptoms as part of relapse prevention or recovery planning, add language connecting hormone-related vulnerabilities (sleep loss, mood instability) to substance use triggers and coping strategies.
  • If you're in a group practice, agency, or hospital system: conduct staff training on menopause-SUD connections within 6 months. Brief your clinicians on the bidirectional relationship between menopausal symptoms and substance use so they recognize that improved sleep or mood management (via hormonal therapy, exercise, medication) may directly reduce relapse risk.
  • Strengthen referral relationships with OB/GYN and primary care providers in your network. When you identify midlife women with unmanaged menopausal symptoms, coordinate directly with their medical providers rather than managing only psychiatric/SUD aspects in isolation.
  • Bookmark SAMHSA's menopause resources and FindTreatment.gov for patient handouts. Use these to reduce stigma during intake and to educate patients that menopause-related substance use is a recognized clinical phenomenon, not a character flaw—this improves early engagement with care.

Notable excerpts

"One important yet often overlooked factor is the connection between menopause and substance use. Emerging evidence shows that going through the menopause transition can influence substance use patterns, including a woman's risk of escalating substance use and recurrence after a period of recovery." — Berlina Wallace-Berube, SAMHSA Center for Substance Abuse Treatment
"Despite these challenges, menopause is not usually considered in substance use disorder prevention, screening, treatment, or recovery programs. This gap highlights the need for more awareness, better guidance for providers, and care that is tailored for women in midlife." — SAMHSA guidance
View full source text
Date: May 14, 2026 Categories: Substance Use, Treatment, Recovery, Mental Health, Substance Use Disorder (SUD) By: Berlina Wallace-Berube, MACP, MEd, LPC, NCC, Senior Public Health Advisor, Center for Substance Abuse Treatment For many women, midlife is a period of significant biological, psychological, and social changes. One of the biggest is menopause, and there’s a growing understanding of how these hormonal changes can affect mood, sleep, cognition, and stress response. One important yet often overlooked factor is the connection between menopause and substance use. Emerging evidence shows that going through the menopause transition can influence substance use patterns, including a woman’s risk of escalating substance use and recurrence after a period of recovery. Recognizing menopause as part of the substance use continuum is critical to improving health outcomes for women. An Overlooked Window of Risk For most women, the transition to menopause can last for years. It includes perimenopause, which typically lasts about four years on average but can extend longer, and post-menopause, which begins after 12 consecutive months without a menstrual period and continues for the remainder of life. Common symptoms include anxiety, depression, insomnia, and chronic pain. Sleep disturbance is especially common and linked to broader health risks among women in midlife. Hormonal changes can intensify emotional distress, and many women also experience other stressful life transitions such as caregiving responsibilities, career changes, and social isolation. Women may use substances in an attempt to cope with all of these difficult changes. Some women may drink alcohol or use other substances to manage symptoms such as insomnia or mood changes. Others may increase existing use as symptoms intensify. Cannabis use is increasing among women in midlife, often for relief of such symptoms as sleep disturbance, anxiety or pain. Impacts on Treatment and Recovery Lack of awareness of the connection between menopause symptoms and substance use may keep women from seeking care. In addition, substance use and menopause can have a bidirectional relationship, meaning they influence each other over time. Sleep disruption and mood instability may make it harder to stay in treatment, while co-occurring conditions may complicate diagnosis and care planning. If these symptoms aren’t addressed, the risk of returning to substance use may increase. Women in recovery may also face a higher risk of returning to substance use during the menopausal transition, and co-occurring mental health conditions can make people more vulnerable, especially because symptoms can worsen during menopause. Despite these challenges, menopause is not usually considered in substance use disorder prevention, screening, treatment, or recovery programs. This gap highlights the need for more awareness, better guidance for providers, and care that is tailored for women in midlife. Moving Toward Menopause-Informed Care This May, SAMHSA is sponsoring its first-ever symposium on how menopause symptoms fit into the substance use disorder prevention, treatment, and recovery continuum of care. The goal is to bring together clinicians, researchers, and policymakers to collaborate, share information and evidence-based practices, and identify gaps in screening, treatment, and prevention. Addressing menopause within substance use disorder prevention, treatment, and recovery requires coordinated strategies. This includes routine screening for substance use disorders across primary care, OB/GYN, and behavioral health settings, as well as trauma-informed care approaches. Strengthening collaboration between behavioral health and women’s health providers is also essential. Expanding workforce training and public awareness can help ensure that providers are better equipped to recognize and address menopause-related risks. Integrating menopause into prevention, treatment, and recovery efforts can support earlier identification of risk, more tailored care, and improved long-term outcomes for midlife women. Resources for women experiencing midlife transitions, substance use disorders, or both If you or someone you know is experiencing challenges related to menopause or substance use, do not wait to seek support. Learning how symptoms such as sleep disruption, mood changes, and stress can influence substance use can help reduce stigma and encourage earlier engagement with care. Sharing resources and supporting community efforts can also help advance more coordinated, person-centered approaches. The U.S. Department of Health and Human Services (HHS) offers a range of resources for individuals, families, providers, and communities: - Substance Use – a comprehensive resource on SAMHSA’s website where you can learn about substances, prevention, treatment, and recovery. - SAMHSA: Substance Use Disorder Treatment – a comprehensive resource with information about substance use, resources, and treatment and recovery options for substance use disorders and co-occurring disorders. - Office on Women’s Health: Menopause – a resource providing clear, reliable information on the stages of menopause, common symptoms, health impacts, and options for symptom management and overall well-being. - CDC: Menopause, Women’s Health, and Work – a resource providing an overview of menopause, including common symptoms such as sleep disruption and mood changes, along with guidance on managing symptoms and understanding their impact on daily life and workplace functioning. - National Institute on Aging: What Is Menopause? – a resource explaining menopause as a natural stage of aging, including information on hormonal changes, common symptoms and their impact on overall health and well-being. - Agency for Healthcare Research and Quality: Menopause – a resource providing an overview of menopause as a natural life stage and evidence-based approaches to managing symptoms and improving quality of life. - HHS Office on Women’s Health: Advancing Women’s Health Through Collaboration – a resource highlighting a federal partnership to improve awareness, education, and evidence-based care for postmenopausal health conditions. - FindTreatment.gov – a confidential and anonymous resource for persons seeking treatment for mental health conditions and substance use disorders (operated by SAMHSA). - 988 Suicide & Crisis Lifeline – a SAMHSA-operated lifeline for individuals in need of support or in crisis. Call or text 988 or chat 988lifeline.org.
SourceThe tracker does not paraphrase a secondary source and present it as the item.

Read the original policy source.

Primary source text, linked directly.

https://www.samhsa.gov/blog/why-menopause-matters-substance-use-disorder-prevention-treatment-recovery

Analysis by
Therapy Companion policy engine
Confidence
high
Analyzed
July 28, 2026
RelatedSame category, or an overlapping jurisdiction.

Related policy changes.

Policy drives denials

Track what affects your practice.

Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.